Moderna shares were falling after the biotech revealed data that might hurt its vaccine’s competitive position.
Read full NASCAR article on Yahoo Sports
Read all NASCAR articles
Home » Moderna’s RSV Vaccine May Lose Efficacy Faster Than GSK and Pfizer’s